Products
Online Inquiry
CAY10698
Cat. No.:
OB0225WX-1842
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
CAY10698 functions as a specific 12-lipoxygenase (12-LO) inhibitor, demonstrating a half-maximal inhibitory concentration (IC50) of 5.1 μM.
Synonym:
684236-01-9; 4-[[(2-Hydroxy-3-methoxyphenyl)methyl]amino]-N-2-thiazolyl-benzenesulfonamide; 4-[(2-hydroxy-3-methoxyphenyl)methylamino]-N-(1,3-thiazol-2-yl)benzenesulfonamide; 4-((2-Hydroxy-3-methoxybenzyl)amino)-N-(thiazol-2-yl)benzenesulfonamide; 4-[(2-hydroxy-3-methoxybenzyl)amino]-N-1,3-thiazol-2-ylbenzenesulfonamide; 4-[(2-hydroxy-3-methoxybenzyl)amino]-N-(1,3-thiazol-2-yl)benzenesulfonamide
CAS No.:
684236-01-9
Compound CID:
1079729
Formula:
C17H17N3O4S2
Formula Weight:
391.46
Specification
Targets&IC50:
12-LOX: 5.1 µM
Relative Density:
1.483 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CAY10698 is applied in inflammatory research as a selective 12/15-lipoxygenase inhibitor to investigate the role of arachidonic acid metabolites in the progression of metabolic and vascular diseases.
Library Information
Target:
Lipoxygenase
Receptor:
12-Lipoxygenase
Pathways:
Metabolism
Plate Number:
AOCL-24
Plate Location:
f3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
45 mg/mL; 114.95 mM
